Stay updated on Troriluzole Long-term Safety in OCD Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.

Latest updates to the Troriluzole Long-term Safety in OCD Clinical Trial page
- ChecktodayChange DetectedThe Record History now shows a new latest revision, v3.5.4, replacing the previous v3.5.3, reflecting an update to the page.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, signaling a new version of the page.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision entry v3.5.2 was added and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry v3.5.0 was added to the record history.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2, indicating a minor system update. No study data or visible page content is changed.SummaryDifference0.1%

- Check72 days agoChange DetectedEntries for Sponsor Decision and Terminated were added on 2026-02-25, and Study Design, Study Status, and Recruitment Status were updated on 2026-02-23. The recruitment option 'Enrolling by invitation' was removed on 2026-01-20.SummaryDifference0.6%

Stay in the know with updates to Troriluzole Long-term Safety in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.